Investigating the Lowest Threshold of Vascular Benefits from LDL Cholesterol Lowering with a PCSK9 mAb Inhibitor (Alirocumab) in Patients with Stable Cardiovascular Disease (INTENS...

by Paul J Cacciottolo, Michalis S Kostapanos, Elena Hernan Sancho, Fotini Kaloyirou, Evangelia Vamvaka, Joanna Helmy, Annette Hubsch
Published 2021-04-01

Effects of oral lycopene supplementation on vascular function in patients with cardiovascular disease and healthy volunteers: a randomised controlled trial.

by Parag R Gajendragadkar, Annette Hubsch, Kaisa M Mäki-Petäjä, Martin Serg, Ian B Wilkinson, Joseph Cheriyan
Published 2014-01-01

Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summa...

by Carmel M. McEniery, Marie Fisk, Karen Miles, Fotini Kaloyirou, Annette Hubsch, Jane Smith, Ian B. Wilkinson, Joseph Cheriyan
Published 2020-07-01

ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study p...

by Carmel M. McEniery, Marie Fisk, Karen Miles, Fotini Kaloyirou, Evangelia Vamvaka, Annette Hubsch, Jane Smith, Ian B. Wilkinson, Joseph Cheriyan
Published 2020-07-01

P29 MECHANISMS OF VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITION INDUCED HYPERTENSION

by Kaisa Maki-Petaja, Adam McGeoch, Lucy Yang, Annette Hubsch, Carmel McEniery, Fraz Mir, Parag Gajendragadkar, Nicola Ramenatte, Gayathri Anandappa, Christoph Brune, Yoeri Boink, Carola Bibiane-Schonlieb, Paul Meyer, Simon Bond, Ian Wilkinson, Duncan Jodrell, Joseph Cheriyan
Published 2018-12-01